Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

drug-development

A collection of 14 Posts

Novo Nordisk Acquires Akero Therapeutics for $5 Billion to Bolster Liver Disease Pipeline post image
Acquisition pharma-industry M&A Activity pharma-mergers drug-development biotech

Novo Nordisk Acquires Akero Therapeutics for $5 Billion to Bolster Liver Disease Pipeline

Featured post
by Newsdesk
Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion, Bolstering Metabolic and Liver Disease Pipeline post image
Acquisition M&A Activity pharma-mergers biotech drug-development

Novo Nordisk to Acquire Akero Therapeutics for $4.7 Billion, Bolstering Metabolic and Liver Disease Pipeline

by Newsdesk
India's CDSCO Reviews New Drug Approval Process to Foster Fairness and Innovation post image
fda Regulation Regulatory Policy regulatory healthcare-policy drug-development

India's CDSCO Reviews New Drug Approval Process to Foster Fairness and Innovation

Featured post
by Newsdesk
Eli Lilly Commits $1 Billion to Expand India Manufacturing and R&D Capabilities post image
pharma-industry Digital Health Industry Trends pharmaceutical healthcare-funding drug-development

Eli Lilly Commits $1 Billion to Expand India Manufacturing and R&D Capabilities

Featured post
by Newsdesk
Aptamer Group Secures Major Pharma Contract for Targeted Radiopharmaceutical Development post image
Therapeutic Platforms biotech drug-development therapeutics

Aptamer Group Secures Major Pharma Contract for Targeted Radiopharmaceutical Development

by Newsdesk
Sapu Nano Initiates Phase 1 Clinical Trial for Novel IV Deciparticle™ Everolimus in Oncology post image
Development Milestones clinical-trials oncology drug-development Clinical Trials

Sapu Nano Initiates Phase 1 Clinical Trial for Novel IV Deciparticle™ Everolimus in Oncology

by Newsdesk
MapLight Therapeutics Targets $704.3M Valuation in US IPO to Fund CNS Drug Pipeline post image
IPO Activity Venture Funding funding healthcare-funding biotech drug-development

MapLight Therapeutics Targets $704.3M Valuation in US IPO to Fund CNS Drug Pipeline

Featured post
by Newsdesk
Serina Therapeutics Advances Parkinson's Drug SER-252 to Global Registrational Trial with $5M Funding Tranche, IND Submitted post image
Development Milestones clinical-trials drug-development regulatory

Serina Therapeutics Advances Parkinson's Drug SER-252 to Global Registrational Trial with $5M Funding Tranche, IND Submitted

by Newsdesk
Leen Kawas: Championing Patient-Centric Innovation and Diverse Leadership in Biotech post image
Startup Innovation biotech healthcare-funding drug-development

Leen Kawas: Championing Patient-Centric Innovation and Diverse Leadership in Biotech

by Newsdesk
World Orphan Drug Congress Europe 2025 to Convene in Amsterdam, Focusing on Rare Disease R&D post image
pharma-industry Breakthrough Research rare-diseases orphan-drugs drug-development

World Orphan Drug Congress Europe 2025 to Convene in Amsterdam, Focusing on Rare Disease R&D

by Newsdesk
Hanmi Pharmaceutical's Encequidar Deal with Gilead Sciences Boosts Shares Amid Global Market Shifts post image
Market Analysis pharmaceutical drug-development market-access

Hanmi Pharmaceutical's Encequidar Deal with Gilead Sciences Boosts Shares Amid Global Market Shifts

by Newsdesk
Global Protein Expression Market Projected to Reach $6.60 Billion by 2032, Driven by Biologics Demand and AI Innovation post image
Market Analysis biotech pharmaceutical drug-development

Global Protein Expression Market Projected to Reach $6.60 Billion by 2032, Driven by Biologics Demand and AI Innovation

by Newsdesk